In the wake of a global pandemic, the life sciences industry has risen to the occasion, supplying vital medicines and developing new therapeutics, diagnostics and vaccines in the fight against COVID-19. However, it’s also disrupted research, clinical trials and supply chains at a time when the sector was contending with significant financial and operational challenges.
Operational efficiency is more important now than ever for biotechnology, pharmaceutical and medical device companies. Our guide provides ways to leverage your third-largest expense – real estate and facilities – to be cost-effective and improve cash flow, opening up much-needed resources to invest in R&D.
Download our comprehensive guidebook, 14 real estate strategies to reduce costs and fuel Life Sciences R&D, for an in-depth look into how you can reduce costs, recapture revenue and thrive.
Fill out this form to download our guide
PRIVACY NOTICE
Jones Lang LaSalle (JLL), together with its subsidiaries and affiliates, is a leading global provider of real estate and investment management services. We take our responsibility to protect the personal information provided to us seriously.
Generally the personal information we collect from you are for the purposes of dealing with your enquiry.
We endeavor to keep your personal information secure with appropriate level of security and keep for as long as we need it for legitimate business or legal reasons. We will then delete it safely and securely. For more information about how JLL processes your personal data, please view our privacy statement.